Infant Bacterial Therapeutics AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2023-05-23 | Infant Bacterial Therapeutics AB | Staffan Strömberg | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 50 000 | 3,29 | SEK | 164 500 | 2023-05-19 |
| 2023-05-24 | Infant Bacterial Therapeutics AB | Robert Molander | Other senior executive | Acquisition | 20 000 | 3,29 | SEK | 65 800 | 2023-05-19 |
| 2023-05-25 | Infant Bacterial Therapeutics AB | Anders Kronström | Other senior executive | Acquisition | 1 329 | 42,5 | SEK | 56 482,5 | 2023-05-22 |
| 2023-06-11 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 1 086 | 46 | SEK | 49 956 | 2023-06-08 |
| 2023-06-28 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Subscription | 200 | 45 | SEK | 9 000 | 2023-06-25 |
| 2023-06-30 | Infant Bacterial Therapeutics AB | Margareta Hagman | Member of the Board of Directors | Subscription | 714 | 45 | SEK | 32 130 | 2023-06-28 |
| 2023-06-30 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Subscription | 284 | 45 | SEK | 12 780 | 2023-06-28 |
| 2023-07-03 | Infant Bacterial Therapeutics AB | Anders Kronström | Other senior executive | Subscription | 1 899 | 45 | SEK | 85 455 | 2023-06-28 |
| 2023-07-03 | Infant Bacterial Therapeutics AB | Staffan Strömberg | Chief Executive Officer (CEO)/Managing Directory | Subscription | 17 817 | 45 | SEK | 801 765 | 2023-06-28 |
| 2023-07-03 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Subscription | 640 | 45 | SEK | 28 800 | 2023-06-28 |
| 2023-07-03 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Subscription | 277 | 45 | SEK | 12 465 | 2023-06-28 |
| 2023-07-16 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 210 | 70,94 | SEK | 14 897,4 | 2023-07-13 |
| 2023-07-16 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 210 | 71,06 | SEK | 14 922,6 | 2023-07-13 |
| 2023-07-19 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 96 | 77,8 | SEK | 7 468,8 | 2023-07-17 |
| 2023-08-28 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 312 | 89,732 | SEK | 27 996,4 | 2023-08-24 |
| 2023-09-07 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 34 | 86 | SEK | 2 924 | 2023-09-05 |
| 2023-10-02 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 39 | 78,8 | SEK | 3 073,2 | 2023-10-01 |
| 2023-11-23 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 442 | 90,4 | SEK | 39 956,8 | 2023-11-21 |
| 2023-12-13 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 350 | 86 | SEK | 30 100 | 2023-12-12 |
| 2023-12-13 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 700 | 86,2 | SEK | 60 340 | 2023-12-12 |